Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sinopharm Group Co ( (HK:1099) ) has provided an update.
Sinopharm Group Co. Ltd., a leading pharmaceutical distributor and healthcare services provider in China, has announced a proposed final cash dividend of RMB 0.69 per share for the financial year ended 31 December 2025. The dividend, to be paid in Hong Kong dollars with the exact amount and exchange rate to be announced, underscores the group’s ongoing profitability and commitment to returning cash to shareholders.
The payout is subject to shareholder approval on 18 June 2026, with an ex-dividend date of 23 June, a record date of 30 June, and payment scheduled for 18 August 2026. The company has detailed withholding tax arrangements for different categories of non-resident enterprise and individual shareholders, as well as mainland investors using Stock Connect, which will affect net dividend receipts and is important for investors’ tax planning and after-tax yield expectations.
The most recent analyst rating on (HK:1099) stock is a Buy with a HK$23.00 price target. To see the full list of analyst forecasts on Sinopharm Group Co stock, see the HK:1099 Stock Forecast page.
More about Sinopharm Group Co
Sinopharm Group Co. Ltd. is a major Chinese pharmaceutical distributor and healthcare services provider, listed in Hong Kong. The company focuses on the distribution of medicines and medical products, supporting hospitals, pharmacies, and other healthcare institutions across mainland China and international markets.
YTD Price Performance: 7.30%
Average Trading Volume: 5,313,248
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$65.1B
For an in-depth examination of 1099 stock, go to TipRanks’ Overview page.